Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–50 of 222 pages matching "alzheimers"

⚙️ Sleep and Circadian Dysfunction in Alzheimer's DiseaseKG

mechanism · 8,066 words · 72 hyp60 ana60 exp

🏥 Alzheimer's DiseaseKG

disease · 5,265 words · 488 hyp63 ana285 exp

🧪 Novartis Alzheimer's Disease Phase 2 Trial (NCT07094516)KG

clinical · 4,079 words · 71 hyp28 ana65 exp

💊 Nanomedicine Approaches to Alzheimer's DiseaseKG

therapeutic · 3,864 words · 56 hyp29 ana54 exp

🧪 Rotigotine and Rivastigmine Combination Therapy for Alzheimer's Disease (NCT06702124)KG

clinical · 3,657 words · 59 hyp35 ana50 exp

🧪 BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer's DiseaseKG

clinical · 3,627 words · 41 hyp22 ana64 exp

⚙️ autophagy-lysosomal-alzheimersKG

mechanism · 3,555 words · 136 hyp64 ana15 exp

🏛️ Alzheimer's Drug Discovery Foundation (ADDF)KG

institution · 3,518 words · 16 hyp13 ana1 exp

iron-calcium-glymphatic-convergence-alzheimersKG

general · 3,516 words · 148 hyp62 ana1 exp

⚙️ Calcium Signaling Dysregulation in Alzheimer's DiseaseKG

mechanism · 3,484 words · 191 hyp69 ana54 exp

⚙️ Sporadic Alzheimer's Disease PathwayKG

mechanism · 3,441 words · 62 hyp57 ana57 exp

⚙️ DNA Damage Response in Alzheimer's DiseaseKG

mechanism · 3,362 words · 94 hyp58 ana103 exp

al002-trem2-agonist-alzheimersKG

clinical_trial · 3,309 words · 52 hyp27 ana9 exp

Choroid-Plexus-in-Alzheimers-DiseaseKG

cell_type · 3,303 words · 211 hyp22 ana18 exp

⚙️ Circadian Rhythm Dysfunction in Alzheimer's DiseaseKG

mechanism · 3,281 words · 75 hyp64 ana58 exp

🏥 DLB, Parkinson's Disease, and Alzheimer's Disease: Cross-Disease Comparison MatrixKG

disease · 3,237 words · 111 hyp35 ana294 exp

⚙️ Biomarkers of Alzheimer DiseaseKG

mechanism · 3,115 words · 183 hyp71 ana21 exp

⚙️ calcium-dysregulation-alzheimersKG

mechanism · 3,111 words · 119 hyp63 ana4 exp

⚙️ Neuroinflammation in Alzheimer's DiseaseKG

mechanism · 3,095 words · 54 hyp51 ana72 exp

⚙️ Familial Alzheimer's Disease GeneticsKG

mechanism · 3,072 words · 47 hyp50 ana59 exp

⚙️ Neuroinflammation in Alzheimer's DiseaseKG

mechanism · 3,061 words · 64 hyp53 ana74 exp

Cerebellar Granule Cells In Alzheimers DiseaseKG

cell_type · 3,049 words · 16 hyp23 ana1 exp

⚙️ Monoclonal Antibody Therapy in Alzheimer's DiseaseKG

mechanism · 3,043 words · 91 hyp62 ana54 exp

⚙️ [AD](/diseases/alzheimers-disease) Failed Approaches AnalysisKG

mechanism · 3,014 words · 22 hyp59 ana4 exp

⚙️ Tau Pathology Alters Oligodendrocyte Gene Methylation in [Alzheimer's Disease](/diseases/alzheimers-disease)KG

mechanism · 3,013 words · 67 hyp53 ana48 exp

⚙️ Metabolic Dysfunction in Alzheimer's DiseaseKG

mechanism · 3,005 words · 108 hyp71 ana59 exp

🏢 Academic Spin-out Companies in Alzheimer’s DiseaseKG

company · 2,931 words · 10 hyp20 ana1 exp

xpro1595-tnf-alpha-inhibitor-alzheimersKG

clinical_trial · 2,899 words · 13 hyp11 ana5 exp

🏛️ Alzheimer's SocietyKG

institution · 2,886 words · 15 hyp15 ana1 exp

⚙️ Nanomedicine for Alzheimer's DiseaseKG

mechanism · 2,857 words · 43 hyp49 ana54 exp

⚙️ Ferroptosis in Alzheimer's DiseaseKG

mechanism · 2,822 words · 75 hyp64 ana58 exp

🔬 Tuberomammillary Nucleus in Alzheimer's DiseaseKG

cell · 2,796 words · 34 hyp24 ana49 exp

⚙️ Vascular Risk Factors in Alzheimer's DiseaseKG

mechanism · 2,764 words · 41 hyp49 ana50 exp

snk01-nkgen-biotech-alzheimersKG

clinical_trial · 2,755 words · 1 hyp4 ana2 exp

🧪 LHP588: P. gingivalis Targeting for Alzheimer's Disease (NCT06847321)KG

clinical · 2,741 words · 40 hyp27 ana50 exp

🧪 EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer's DiseaseKG

clinical · 2,740 words · 35 hyp31 ana50 exp

🏛️ alzheimers-research-ukKG

institution · 2,717 words · 38 hyp18 ana1 exp

APOE contributes to Alzheimer's disease by regulating both beta-amyloid depositionKG

hypothesis · 2,704 words · 69 hyp10 ana48 exp

🏛️ Alzheimer's AssociationKG

institution · 2,680 words · 6 hyp10 ana1 exp

alzheimers-diseaseKG

clinical_trial · 2,667 words · 26 hyp21 ana9 exp

🧫 Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecular Basis and EnhancementKG

experiment · 2,622 words · 63 hyp62 ana56 exp

⚙️ SYK Kinase in Microglial Activation and Alzheimer's DiseaseKG

mechanism · 2,557 words · 71 hyp56 ana57 exp

⚙️ Necroptosis in Alzheimer's DiseaseKG

mechanism · 2,534 words · 36 hyp51 ana52 exp

remternetug-anti-amyloid-alzheimersKG

clinical_trial · 2,526 words · 23 hyp13 ana19 exp

🔬 Frontal Cortex Neurons in Alzheimer's DiseaseKG

cell · 2,506 words · 37 hyp30 ana48 exp

⚙️ Sex-Specific Mechanisms in Alzheimer's DiseaseKG

mechanism · 2,499 words · 51 hyp52 ana58 exp

🔬 Cholinergic Basal Forebrain Neurons in Alzheimer's DiseaseKG

cell · 2,495 words · 50 hyp30 ana51 exp

🏛️ alzheimers-clinical-trial-consortiumKG

institution · 2,459 words · 39 hyp18 ana1 exp

Alzheimer's disease pathology originates in the hippocampus and subsequently spreadsKG

hypothesis · 2,427 words · 25 hyp20 ana47 exp

🧪 Interleukin-2 Phase 2 (NCT06096090) — Immunomodulation for ADKG

clinical · 2,399 words · 20 hyp11 ana6 exp